F, K., D, C., K, T., S, v. K., T, T., B, H., . . . DA, F. (2023). Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Cost-Effectiveness Study. Annals of internal medicine, 176(7), 949. https://doi.org/10.7326/M22-3559
Chicago Style (17th ed.) CitationF, Khan, Coyle D, Thavorn K, van Katwyk S, Tritschler T, Hutton B, Le Gal G, Rodger MA, and Fergusson DA. "Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Cost-Effectiveness Study." Annals of Internal Medicine 176, no. 7 (2023): 949. https://doi.org/10.7326/M22-3559.
MLA (9th ed.) CitationF, Khan, et al. "Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Cost-Effectiveness Study." Annals of Internal Medicine, vol. 176, no. 7, 2023, p. 949, https://doi.org/10.7326/M22-3559.